U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07638007) titled 'Impact of Targeted Therapy on Cancer-Related Cognitive Impairment' on April 22.
Brief Summary: This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.
Study Start Date: Nov. 21, 2025
Study Type: OBSERVATIONAL
Condition:
Disease/Condition Name Cancer-related Cognitive Dysfunction
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia, BCR-ABL1 Positive
Recruitment Status: RECRUITING
Sponsor: University of Rochester NCORP Research Base
Information provided by (Responsible Party): Michelle Janelsins...